Studies on the Constituents of Lyonia Ovalifolia SIEB. Et ZUCC. Var. Elliptica HAND.-MAZZ

Yakugaku Zasshi - Japan
doi 10.1248/yakushi1947.79.3_403
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Studies on the Constituents of Lyonia Ovalifolia DRUDE Var. Elliptica HAND.-MAZZ. XVI. : Structure of Triterpenoid Glucoside, Lyofolic Acid. (2)

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1971English

Studies on the Constituents of Lyonia Ovalifolia Var. Elliptica. VIII. : On the Terpenoid Constiuents of the Red Shoots

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1969English

Studies on the Constituents of the Leaves of Lyonia Ovalifolia DRUDE in Nepal

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1974English

Studies on the Constituents of Sophora Species. IV. : Constituents of the Root of Sophora Angustifolia SIEB. Et ZUCC. (1)

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1970English

Studies on Constituents of Medical Plants. VII. : The Constituents of the Bark and Fruit of Clethra Barbinervis SIEB. Et ZUCC.

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1966English

Tannins and Related Compounds. LII Studies on the Constituents of the Leaves of Thujopsis Dolabrata SIEB. Et ZUCC.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1987English

Studies on the Alkaloids of Thalictrum Actaefolium SIEB. Et ZUCC. I

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1962English

Constituents of Geranium Thunbergii Sieb. Et Zucc. IV. Ellagitannins. 2. Structure of Geraniin.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1977English

Studies on the Constituents of Ligustrum Species. XIII. : Structures of Phenylethanoid Glycosides From the Leaves of Ligustrum Obtusifolium SIEB. Et ZUCC.

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy